DNA X Inc
SONMNo date yet
Revenue by quarter
$ millionsDiluted EPS by quarter
$ per share, as reportedOn today’s share basis: figures from before a stock split are divided by it, so every quarter compares.
‡ A fourth quarter is the year’s EPS less the first three quarters’, calculated by The Dispatch: a 10-K reports the year, not the quarter. It can differ by a cent or two from the company’s own figure, because the share count moves during the year.
EPS against the average estimate
| Quarter | Average estimate | Reported | Difference |
|---|---|---|---|
| Q3 2024 | -$12.12 | -$9.36 | EPS came in $2.76 above the average estimate |
| Q2 2024 | -$9.91 | -$25.38 | EPS came in $15.47 below the average estimate |
| Q1 2024 | -$5.51 | -$12.60 | EPS came in $7.09 below the average estimate |
| Q4 2023 | $1.84 | -$5.40 | EPS came in $7.24 below the average estimate |
Both from Finnhub. Its reported figures are on the same basis as analysts’ estimates, which usually leave out some one-off items, so they can differ from the diluted EPS above, which is as filed with the SEC.
Revenue and EPS: DNA X Inc's 10-Q and 10-K filings, from SEC EDGAR. Outlooks: the company's earnings releases (exhibit 99.1 to its 8-K filings), quoted as written; only a revenue figure stated for the coming quarter is read, and the last five releases are checked. Next report date and estimates: Finnhub.